Aevi Genomic Medicine Competitors and Similar CompaniesClear all

Aevi Genomic Medicine's competitors and similar companies include AnGes, Lexicon Pharmaceuticals, Intellia Therapeutics and CRISPR Therapeutics.

	Aevi Genomic Medicine Aevi Genomic Medicine is a clinical stage biopharmaceutical company.	AnGes AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine.	Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.	Intellia Therapeutics Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.	CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
Founding Date	Founding Date 2000	Founding Date 1999	Founding Date 1995	Founding Date 2014	Founding Date 2013
Type	Type Subsidiary	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech clinical research healthtech	Tags Healthcare biotech drug development genetics pharma
Locations	Locations Wayne, US HQ San Francisco, US	Locations Ibaraki, JP HQ Fujisawa, JP Ibaraki, JP Kawasaki, JP Minato City, JP Bethesda, US	Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more	Locations Cambridge, US HQ	Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US
Employees	Employees 1418% decrease	Employees 5562% decrease	Employees 20216% increase	Employees 40323% decrease	Employees 393
Valuation ($)	Valuation ($) N/A	Valuation ($) 78.3 m	Valuation ($) 737.4 m	Valuation ($) 1.7 b	Valuation ($) 4.2 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥874.1m (FY, 2025)	Revenue (est.) $49.8m (FY, 2025)	Revenue (est.) $67.7m (FY, 2025)	Revenue (est.) $3.5m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods ¥499.9m (FY, 2025)	Cost of goods $274k (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ¥374.2m (FY, 2025)	Gross profit $49.5m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ($30.8m) (FY, 2018)	Net income (¥5.1b) (FY, 2025)	Net income ($50.3m) (FY, 2025)	Net income ($412.7m) (FY, 2025)	Net income ($581.6m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 7m	Total funding raised N/A	Total funding raised $ 244.7m	Total funding raised N/A	Total funding raised $ 127m